Triple therapy with vinblastine, interferon-alpha 2a and zidovudine for AIDS-related Kaposi's sarcoma
Borleffs, J.C.; Hoepelman, I.M.; van der Ende, M.E.; van Leusen, R.; van 't Wout, J.W.
Journal of Acquired Immune Deficiency Syndromes 4(11): 1161-1162
1991
ISSN/ISBN: 0894-9255 PMID: 1753344 Document Number: 379328
Document emailed within 1 workday
Related Documents
Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10Krown, S.E.; Gold, J.W.; Niedzwiecki, D.; Bundow, D.; Flomenberg, N.; Gansbacher, B.; Brew, B.J. 1990: Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS) Annals of Internal Medicine 112(11): 812-821
Abrams, D.I.; Volberding, P.A. 1987: Alpha interferon therapy of AIDS-associated Kaposi's sarcoma Seminars in Oncology 14(2 Suppl 2: 43-47
Mitsuyasu, R.T. 1989: The enhanced potential use of recombinant alpha interferon in the treatment of AIDS-related Kaposi's sarcoma Oncology Nursing Forum 16(6): 5-7
Ghyka, G.; Alecu, M.; Hălălău, F.; Călugăru, A.; Coman, G. 1991: Human leukocyte interferon treatment associated with IL-2 in the non-AIDS related Kaposi's sarcoma Romanian Journal of Internal Medicine 29(1-2): 75-83
Alecu, M.; Ghyka, G.; Hălălău, F.; Călugăru, A.; Coman, G. 1990: Intralesional human leukocyte interferon treatment in the non-AIDS related Kaposi's sarcoma Medecine Interne 28(1): 61-67
Murakami-Mori, K.; Mori, S.; Taga, T.; Kishimoto, T.; Nakamura, S. 1997: Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation Journal of Immunology 158(11): 5518-5526
Murakami-Mori, K.; Mori, S.; Bonavida, B.; Nakamura, S. 1999: Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells Journal of Immunology 162(6): 3672-3679
Plettenberg, A.; Albrecht, D.; Lorenzen, T.; Meyer, T.; Arndt, R.; Stoehr, A. 2002: Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma European Journal of Medical Research 7(1): 19-24
Krown, S.E. 1987: The role of interferon in the therapy of epidemic Kaposi's sarcoma Seminars in Oncology 14(2 Suppl 3: 27-33
Stadler, R.; Bratzke, B.; Orfanos, C.E. 1987: Therapeutic use of alpha interferon in metastasizing malignant melanoma, disseminated Kaposi sarcoma and severe Behçet disease Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 38(8): 453-460
Biggar, R.J.; Nasca, P.C.; Burnett, W.S. 1988: AIDS-related Kaposi's sarcoma in New York City in 1977 New England Journal of Medicine 318(4): 252
Von Overbeck, J.; Perey, L.; Iten, A.; Pechère, M.; Ruffieux, P.; Hirschel, B. 1995: Human chronic gonadotropin for AIDS-related Kaposi's sarcoma Lancet 346(8975): 642-643
Mallery, S.R.; Bailer, R.T.; Hohl, C.M.; Ng-Bautista, C.L.; Ness, G.M.; Livingston, B.E.; Hout, B.L.; Stephens, R.E.; Brierley, G.P. 1995: Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: implication for oxidant stress in AIDS-KS pathogenesis Journal of Cellular Biochemistry 59(3): 317-328
Moyle, G.; Youle, M.; Barton, S. 1993: Intralesional vinblastine in the treatment of oral Kaposi's sarcoma British Journal of Clinical Practice 47(2): 79-80
Dezube, B.J.; Pantanowitz, L.; Aboulafia, D.M. 2004: Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment Aids Reader 14(5): 236-8 243-4 251-3
Ambrus, J.L.; Poiesz, B.J.; Lillie, M.A.; Stadler, I.; Di Berardino, L.A.; Chadha, K.C. 1989: Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals American Journal of Medicine 87(4): 405-407
Pompili, G.G.; Dellafiore, L.; Soldi, S.; Alineri, S.; Bonetto, S.; Santambrogio, S.; Cornalba, G. 1998: AIDS-related pulmonary Kaposi's sarcoma: role of high-resolution computerized tomography La Radiologia Medica 96(4): 318-324
Hermans, P.; Lundgren, J.; Sommereijns, B.; Pedersen, C.; Vella, S.; Katlama, C.; Lüthy, R.; Pinching, A.J.; Gerstoft, J.; Pehrson, P.; Clumeck, N. 1996: Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group Aids 10(8): 911-917
Fischl, M.A.; Richman, D.D.; Causey, D.M.; Grieco, M.H.; Bryson, Y.; Mildvan, D.; Laskin, O.L.; Groopman, J.E.; Volberding, P.A.; Schooley, R.T. 1989: Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group JAMA 262(17): 2405-2410